{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:01:07Z","timestamp":1785319267388,"version":"3.55.0"},"reference-count":112,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>This Clinical Report was retired January 2024.<\/jats:title>\n               <jats:p>The adolescent period heralds the pediatric patient\u2019s transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of the foundations of preventive adolescent health care is timely vaccination, and every visit can be viewed as an opportunity to update and complete an adolescent\u2019s immunizations.<\/jats:p>\n               <jats:p>In the past decade, the adolescent immunization schedule has expanded to include 2 doses of quadrivalent meningococcal conjugate vaccine, 1 dose of tetanus, diphtheria, acellular pertussis, absorbed vaccine, 2 or 3 doses of human papillomavirus vaccine, depending on the child\u2019s age, and an annual influenza vaccine. In addition, during adolescent visits, health care providers can determine whether catch-up vaccination is needed to meet early childhood recommendations for hepatitis B; hepatitis A; measles, mumps, rubella; poliovirus; and varicella vaccines. New serogroup B meningococcal vaccines are now available for those at increased risk for meningococcal disease; in addition, these serogroup B meningococcal vaccines received a Category B recommendation for healthy adolescents, where individual counseling and risk\u2013benefit evaluation based on health care provider judgements and patient preferences are indicated. This clinical report focuses on the epidemiology of adolescent vaccine-preventable diseases by reviewing the rationale for the annual universally recommended adolescent immunization schedule of the American Academy of Pediatrics, the American Academy of Family Physicians, the Centers for Disease Control and Prevention, and the American Congress of Obstetricians and Gynecologists. In addition, the barriers that negatively influence adherence to this current adolescent immunization schedule will be highlighted.<\/jats:p>","DOI":"10.1542\/peds.2016-4186","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T10:10:11Z","timestamp":1486462211000},"source":"Crossref","is-referenced-by-count":37,"title":["The Need to Optimize Adolescent Immunization"],"prefix":"10.1542","volume":"139","author":[{"given":"Henry H.","family":"Bernstein","sequence":"first","affiliation":[{"name":"aDepartment of Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Joseph A.","family":"Bocchini","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COMMITTEE ON INFECTIOUS DISEASES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Byington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne A.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Dele","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lynfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Nolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christine","family":"Nyquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobeen H.","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Q.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoklis E.","family":"Zaoutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"issue":"1","key":"2024013017363603900_B1","doi-asserted-by":"crossref","first-page":"e20153908","DOI":"10.1542\/peds.2015-3908","article-title":"2016 recommendations for pediatric preventive health care.","volume":"137","author":"American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Workgroup","year":"2016","journal-title":"Pediatrics"},{"key":"2024013017363603900_B2","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1542\/peds.2007-1115D","article-title":"Adolescent immunizations and other clinical preventive services: a needle and a hook?","volume":"121","author":"Broder","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"2024013017363603900_B3","doi-asserted-by":"crossref","first-page":"e20154531","DOI":"10.1542\/peds.2015-4531","article-title":"Recommended childhood and adolescent immunization schedule\u2014United States, 2016.","volume":"137","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2016","journal-title":"Pediatrics"},{"key":"2024013017363603900_B4","unstructured":"US Department of Health and Human Services\n          . Healthy People 2020. Immunization and infectious diseases. Available at: www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives. Accessed June 20, 2016"},{"key":"2024013017363603900_B5","unstructured":"Centers for Disease Control and Prevention\n          . Adolescent tetanus and diphtheria toxoids (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination coverage report. Available at: www.cdc.gov\/vaccines\/imz-managers\/coverage\/teenvaxview\/data-reports\/td-tdap\/reports\/2015.html. Accessed January 19, 2017"},{"key":"2024013017363603900_B6","unstructured":"Centers for Disease Control and Prevention\n          . 2015 Adolescent meningococcal conjugate (MenACWY) vaccination coverage report. Available at: www.cdc.gov\/vaccines\/imz-managers\/coverage\/teenvaxview\/data-reports\/menacwy\/reports\/2015.html. Accessed January 19, 2017"},{"key":"2024013017363603900_B7","unstructured":"Centers for Disease Control and Prevention\n          . Flu vaccination coverage, United States, 2015-16 influenza season. Available at: www.cdc.gov\/flu\/fluvaxview\/coverage-1516estimates.htm. Accessed January 19, 2017"},{"issue":"33","key":"2024013017363603900_B8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.15585\/mmwr.mm6533a4","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2015","volume":"65","author":"Reagan-Steiner","year":"2016","journal-title":"MMWR Wkly Rep"},{"issue":"29","key":"2024013017363603900_B9","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"2024013017363603900_B10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MOP.0000000000000228","article-title":"Immunizing adolescents: a selected review of recent literature and US recommendations.","volume":"27","author":"Schneyer","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"2024013017363603900_B11","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1542\/peds.2007-1115B","article-title":"New, and some not-so-new, vaccines for adolescents and diseases they prevent.","volume":"121","author":"Fishbein","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"2024013017363603900_B12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00006454-200106000-00003","article-title":"Strict interpretation of vaccination guidelines with computerized algorithms and improper timing of administered doses.","volume":"20","author":"Butte","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-2","key":"2024013017363603900_B13","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"2024013017363603900_B14","unstructured":"National Foundation for Infectious Diseases\n          . Meningococcal vaccination: improving rates in adolescents and reducing racial, ethnic, and socioeconomic disparities. Available at: www.adolescentvaccination.org\/resources\/meningococcal-cta.pdf. Accessed June 20, 2016"},{"key":"2024013017363603900_B15","unstructured":"Centers for Disease Control and Prevention\n          . Epidemiology and prevention of vaccine-preventable diseases, meningococcal disease.13th ed. Available at: www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/mening.pdf. Accessed June 20, 2016"},{"issue":"1","key":"2024013017363603900_B16","first-page":"237","article-title":"Meningococcal disease: changes in epidemiology and prevention.","volume":"4","author":"Chang","year":"2012","journal-title":"Clin Epidemiol"},{"issue":"18","key":"2024013017363603900_B17","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":"Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"2024013017363603900_B18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-4199","article-title":"Coadministration of a 9-valent human papillomavirus vaccine with meningococcal and Tdap vaccines.","volume":"136","author":"Schilling","year":"2015","journal-title":"Pediatrics"},{"issue":"9","key":"2024013017363603900_B19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"key":"2024013017363603900_B20","unstructured":"MacNeil\u2008J\n          . Epidemiology of serogroup B meningococcal disease, United States. Presented at: Advisory Committee on Immunization Practices Meeting; October 29\u201330, 2014; Atlanta, GA. Available at: www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2014-10\/mening-02-MacNeil.pdf. Accessed June 20, 2016"},{"key":"2024013017363603900_B21","unstructured":"National Foundation for Infectious Diseases\n          . Meningococcal serogroup b cases and outbreaks on US college campuses. Available at: http:\/\/www.nfid.org\/idinfo\/meningococcal\/meningococcal-b-college-outbreaks.htm. Accessed January 19, 2017"},{"issue":"5","key":"2024013017363603900_B22","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2014-4015","article-title":"First use of a serogroup b meningococcal vaccine in the US in response to a university outbreak.","volume":"135","author":"McNamara","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"2024013017363603900_B23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jinf.2014.07.002","article-title":"Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(\u00ae)).","volume":"69","author":"Ladhani","year":"2014","journal-title":"J Infect"},{"key":"2024013017363603900_B24","unstructured":"US Food and Drug Administration\n          . Bexsero package insert. Available at: www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm431446.htm. Accessed June 20, 2016"},{"key":"2024013017363603900_B25","unstructured":"US Food and Drug Administration\n          . Trumenba package insert. Available at: www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm421034.htm. Accessed June 20, 2016"},{"issue":"3","key":"2024013017363603900_B26","doi-asserted-by":"crossref","first-page":"e20161890","DOI":"10.1542\/peds.2016-1890","article-title":"Recommendations for serogroup B meningococcal vaccine for persons 10 years and older.","volume":"138","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"2024013017363603900_B27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0000000000000921","article-title":"Trends in pertussis diagnostic testing in the United States, 1990 to 2012.","volume":"35","author":"Faulkner","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2024013017363603900_B28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MOP.0000000000000139","article-title":"Pertussis: still a cause of death, seven decades into vaccination.","volume":"26","author":"Jakinovich","year":"2014","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"2024013017363603900_B29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tim.2012.03.003","article-title":"Pertussis control: time for something new?","volume":"20","author":"Clark","year":"2012","journal-title":"Trends Microbiol"},{"issue":"12","key":"2024013017363603900_B30","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/cid\/cis287","article-title":"Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.","volume":"54","author":"Witt","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"46","key":"2024013017363603900_B31","article-title":"Notifiable diseases and mortality tables.","volume":"65","author":"Centers for Disease Control and Prevention","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024013017363603900_B32","unstructured":"Centers for Disease Control and Prevention\n          . 2015 Final pertussis surveillance report. November 2016. Available at: https:\/\/www.cdc.gov\/pertussis\/downloads\/pertuss-surv-report-2015-provisional.pdf. Accessed January 19, 2017"},{"key":"2024013017363603900_B33","unstructured":"Centers for Disease Control and Prevention\n          . 2012 final pertussis surveillance report. Available at: www.cdc.gov\/pertussis\/downloads\/pertuss-surv-report-2012.pdf. Accessed August 2015"},{"key":"2024013017363603900_B34","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"2024013017363603900_B35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jadohealth.2008.08.019","article-title":"Adolescent Tdap vaccine use among primary care physicians.","volume":"44","author":"Dempsey","year":"2009","journal-title":"J Adolesc Health"},{"issue":"1","key":"2024013017363603900_B36","first-page":"13","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"2024013017363603900_B37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/GRF.0b013e318181dde1","article-title":"Vaccines for pertussis and influenza: recommendations for use in pregnancy.","volume":"51","author":"Gall","year":"2008","journal-title":"Clin Obstet Gynecol"},{"issue":"7","key":"2024013017363603900_B38","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024013017363603900_B39","unstructured":"Association of Reproductive Health Professionals\n          . Managing HPV: a new era in patient care. Available at: www.arhp.org\/publications-and-resources\/clinical-proceedings\/Managing-HPV\/Impact. Accessed June 20, 2016"},{"key":"2024013017363603900_B40","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"2024013017363603900_B41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"4","key":"2024013017363603900_B42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.","volume":"204","author":"Hariri","year":"2011","journal-title":"J Infect Dis"},{"key":"2024013017363603900_B43","unstructured":"Centers for Disease Control and Prevention\n          . Pink book: human papillomavirus. Available at: www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/hpv.pdf. Accessed June 20, 2016"},{"key":"2024013017363603900_B44","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","article-title":"Updating the natural history of human papillomavirus and anogenital cancers.","volume":"30","author":"Moscicki","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"2024013017363603900_B45","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/OLQ.0000000000000199","article-title":"The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States.","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2024013017363603900_B46","doi-asserted-by":"crossref","first-page":"e20151968","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States.","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"issue":"49","key":"2024013017363603900_B47","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination \u2013 updated recommendations of the advisory committee on immunization practices","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"2024013017363603900_B48","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"2024013017363603900_B49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"2024013017363603900_B50","unstructured":"US Food and Drug Administration\n          . Gardasil 9 package insert. Available at: www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM426457.pdf. Accessed October 27, 2016."},{"issue":"17","key":"2024013017363603900_B51","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"issue":"22","key":"2024013017363603900_B52","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2016.17615","article-title":"Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women.","volume":"316","author":"Iversen","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"2024013017363603900_B53","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MOP.0000000000000354","article-title":"Human papillomavirus epidemiology and vaccine recommendations: selected review of the recent literature.","volume":"28","author":"Seyferth","year":"2016","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"2024013017363603900_B54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"8","key":"2024013017363603900_B55","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/521192","article-title":"Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students.","volume":"196","author":"Partridge","year":"2007","journal-title":"J Infect Dis"},{"issue":"6","key":"2024013017363603900_B56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6506a1","article-title":"Youth Risk Behavior Surveillance - United States, 2015.","volume":"65","author":"Kann","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"2024013017363603900_B57","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines.","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"2024013017363603900_B58","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-3745","article-title":"Immunogenicity and safety of a 9-valent HPV vaccine.","volume":"136","author":"Van Damme","year":"2015","journal-title":"Pediatrics"},{"issue":"37","key":"2024013017363603900_B59","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2012.06.057","article-title":"Reduction of HPV infections through vaccination among at-risk urban adolescents.","volume":"30","author":"Cummings","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"2024013017363603900_B60","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-4144","article-title":"Long-term study of a quadrivalent human papillomavirus vaccine.","volume":"134","author":"Ferris","year":"2014","journal-title":"Pediatrics"},{"issue":"11","key":"2024013017363603900_B61","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/infdis\/jiw046","article-title":"Impact and cost-effectiveness of 3 doses of 9-valent human papillomavirus (HPV) vaccine among US females previously vaccinated with 4-valent HPV vaccine.","volume":"213","author":"Chesson","year":"2016","journal-title":"J Infect Dis"},{"issue":"42","key":"2024013017363603900_B62","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.15585\/mmwr.mm6442a1","article-title":"Human papillomavirus vaccination coverage among female adolescents in managed care plans\u2014United States, 2013.","volume":"64","author":"Ng","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2024013017363603900_B63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0009922814551135","article-title":"Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-year-old U.S. adolescent children.","volume":"54","author":"Rahman","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"key":"2024013017363603900_B64","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ygyno.2014.01.046","article-title":"HPV vaccine use among African American girls: qualitative formative research using a participatory social marketing approach.","volume":"132","author":"Hull","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2024013017363603900_B65","doi-asserted-by":"crossref","first-page":"e20150675","DOI":"10.1542\/peds.2015-0675","article-title":"Improving HPV vaccination rates using Maintenance-of-Certification requirements.","volume":"137","author":"Fiks","year":"2016","journal-title":"Pediatrics"},{"key":"2024013017363603900_B66","unstructured":"Centers for Disease Control and Prevention\n          . HPV vaccine: same way, same day. Available at: www.cdc.gov\/vaccines\/who\/teens\/products\/matte.html. Accessed June 20, 2016"},{"issue":"5","key":"2024013017363603900_B67","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1542\/peds.2013-1493","article-title":"Influenza-associated pediatric deaths in the United States, 2004-2012.","volume":"132","author":"Wong","year":"2013","journal-title":"Pediatrics"},{"key":"2024013017363603900_B68","unstructured":"Centers for Disease Control and Prevention\n          . FluView 2009-2010 influenza-associated pediatric mortality data. Available at: https:\/\/gis.cdc.gov\/GRASP\/Fluview\/PedFluDeath.html. Accessed June 20, 2016"},{"key":"2024013017363603900_B69","unstructured":"Centers for Disease Control and Prevention\n          . FluView influenza-associated pediatric mortality. Available at: http:\/\/gis.cdc.gov\/GRASP\/Fluview\/PedFluDeath.html. Accessed January 19, 2017"},{"issue":"4","key":"2024013017363603900_B70","doi-asserted-by":"crossref","first-page":"e20162527","DOI":"10.1542\/peds.2016-2527","article-title":"Recommendations for prevention and control of influenza in children, 2016-2017.","volume":"138","author":"Committee on Infectious Diseases, American Academy of Pediatrics","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"2024013017363603900_B71","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/01.AOG.0000453599.11566.11","article-title":"Committee opinion no. 608: influenza vaccination during pregnancy.","volume":"124","author":"Committee on Obstetric Practice and Immunization Expert Work Group","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2024013017363603900_B72","volume-title":"Red Book: 2015 Report of the Committee of Infectious Diseases","author":"American Academy of Pediatrics","year":"2015","edition":"30th ed."},{"issue":"2","key":"2024013017363603900_B73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1542\/peds.2011-2197","article-title":"Hepatitis a vaccination coverage among adolescents in the United States.","volume":"129","author":"Dorell","year":"2012","journal-title":"Pediatrics"},{"key":"2024013017363603900_B74","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"2024013017363603900_B75","unstructured":"Centers for Disease Control and Prevention\n          . Measles cases and outbreaks. Available at: www.cdc.gov\/measles\/cases-outbreaks.html. Accessed January 19, 2017"},{"key":"2024013017363603900_B76","unstructured":"Centers for Disease Control and Prevention\n          . Measles (rubeola): for travelers. Available at: www.cdc.gov\/measles\/travelers.html. Accessed June 20, 2016"},{"issue":"5","key":"2024013017363603900_B77","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/INF.0b013e31827f4c3c","article-title":"Factors associated with receipt of two doses of varicella vaccine among adolescents in the United States.","volume":"32","author":"Kawai","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"2024013017363603900_B78","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/1055-9965.EPI-15-0326","article-title":"Quality of physician communication about human papillomavirus vaccine: findings from a national survey.","volume":"24","author":"Gilkey","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2024013017363603900_B79","doi-asserted-by":"crossref","first-page":"e20152488","DOI":"10.1542\/peds.2015-2488","article-title":"Primary care physicians\u2019 perspectives about HPV vaccine.","volume":"137","author":"Allison","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"2024013017363603900_B80","doi-asserted-by":"crossref","first-page":"e20161764","DOI":"10.1542\/peds.2016-1764","article-title":"Announcements versus conversations to improve HPV vaccination coverage: a randomized control trial","volume":"139","author":"Brewer","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"2024013017363603900_B81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3122\/jabfm.18.1.13","article-title":"Barriers to adolescent immunization: a survey of family physicians and pediatricians.","volume":"18","author":"Oster","year":"2005","journal-title":"J Am Board Fam Pract"},{"issue":"9","key":"2024013017363603900_B82","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2105\/AJPH.2009.176628","article-title":"Addressing adolescent immunization disparities: a retrospective analysis of school-based health center immunization delivery.","volume":"100","author":"Federico","year":"2010","journal-title":"Am J Public Health"},{"issue":"24","key":"2024013017363603900_B83","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/j.vaccine.2015.04.064","article-title":"Promoting influenza vaccination: insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC).","volume":"33","author":"Nowak","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"2024013017363603900_B84","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1542\/peds.2009-1962","article-title":"Parental vaccine safety concerns in 2009.","volume":"125","author":"Freed","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"2024013017363603900_B85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1542\/peds.2012-2384","article-title":"Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010.","volume":"131","author":"Darden","year":"2013","journal-title":"Pediatrics"},{"key":"2024013017363603900_B86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1875035401104010003","article-title":"Immunization in adolescents: past, present, and future.","volume":"4","author":"Mameli","year":"2011","journal-title":"Open Vaccine J"},{"key":"2024013017363603900_B87","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1542\/peds.2010-1722P","article-title":"Sources and perceived credibility of vaccine-safety information for parents.","volume":"127","author":"Freed","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"2024013017363603900_B88","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1377\/hlthaff.2011.0396","article-title":"Confidence about vaccines in the United States: understanding parents\u2019 perceptions.","volume":"30","author":"Kennedy","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"2024013017363603900_B89","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1542\/peds.2007-0538","article-title":"Parents with doubts about vaccines: which vaccines and reasons why.","volume":"122","author":"Gust","year":"2008","journal-title":"Pediatrics"},{"key":"2024013017363603900_B90","unstructured":"National Foundation for Infectious Diseases and the National Coalition for Adult Immunization\n          . A report on reaching underserved ethnic and minority populations to improve adolescent and adult immunization rates. Available at: http:\/\/pulse.pharmacy.arizona.edu\/resources\/diseases_epidemic\/pediatricwhitepaper.pdf. Accessed June 20, 2016"},{"issue":"5","key":"2024013017363603900_B91","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1542\/peds.2015-1631","article-title":"HPV vaccination coverage of male adolescents in the United States.","volume":"136","author":"Lu","year":"2015","journal-title":"Pediatrics"},{"issue":"24","key":"2024013017363603900_B92","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.vaccine.2016.04.039","article-title":"Reasons given for not receiving an influenza vaccination, 2011-12 influenza season, United States.","volume":"34","author":"Santibanez","year":"2016","journal-title":"Vaccine"},{"issue":"45","key":"2024013017363603900_B93","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2012.07.085","article-title":"Barriers to HPV immunization for African American adolescent females.","volume":"30","author":"Hamlish","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"2024013017363603900_B94","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0009922812473775","article-title":"Attitudes toward HPV vaccination among low-income and minority parents of sons: a qualitative analysis.","volume":"52","author":"Perkins","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"issue":"5","key":"2024013017363603900_B95","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1542\/peds.2015-1563","article-title":"Promoting HPV vaccination in safety-net clinics: a randomized trial.","volume":"136","author":"Tiro","year":"2015","journal-title":"Pediatrics"},{"issue":"30","key":"2024013017363603900_B96","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.vaccine.2012.04.062","article-title":"Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.","volume":"30","author":"Javanbakht","year":"2012","journal-title":"Vaccine"},{"issue":"52","key":"2024013017363603900_B97","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1016\/j.vaccine.2014.10.068","article-title":"Factors associated with seasonal influenza immunization among church-going older African Americans.","volume":"32","author":"Boggavarapu","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"2024013017363603900_B98","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1542\/peds.2011-3443","article-title":"School-based health centers and pediatric practice.","volume":"129","author":"American Academy of Pediatrics, Council on School Health","year":"2012","journal-title":"Pediatrics"},{"issue":"8","key":"2024013017363603900_B99","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMe1415742","article-title":"HPV \u201ccoverage\u201d.","volume":"372","author":"Schuchat","year":"2015","journal-title":"N Engl J Med"},{"key":"2024013017363603900_B100","unstructured":"Centers for Disease Control and Prevention\n          . CDC vaccine price list. Available at: www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html. Accessed June 20, 2016"},{"issue":"9","key":"2024013017363603900_B101","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2105\/AJPH.2005.078451","article-title":"Impact of the CDC\u2019s Section 317 Immunization Grants Program funding on childhood vaccination coverage.","volume":"96","author":"Rein","year":"2006","journal-title":"Am J Public Health"},{"issue":"2","key":"2024013017363603900_B102","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.amepre.2008.03.033","article-title":"Mandates for adolescent immunizations: recommendations from the National Vaccine Advisory Committee.","volume":"35","author":"National Vaccine Advisory Committee","year":"2008","journal-title":"Am J Prev Med"},{"issue":"1","key":"2024013017363603900_B103","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamapediatrics.2013.2752","article-title":"Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.","volume":"168","author":"Holman","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"24","key":"2024013017363603900_B104","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/j.vaccine.2012.03.067","article-title":"An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010.","volume":"30","author":"Laz","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"2024013017363603900_B105","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2012-1516","article-title":"Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds.","volume":"130","author":"Bednarczyk","year":"2012","journal-title":"Pediatrics"},{"issue":"21","key":"2024013017363603900_B106","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1016\/j.vaccine.2012.02.081","article-title":"Does HPV vaccination affect women\u2019s attitudes to cervical cancer screening and safe sexual behaviour?","volume":"30","author":"Mather","year":"2012","journal-title":"Vaccine"},{"issue":"29","key":"2024013017363603900_B107","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15585\/mmwr.mm6429a3","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2014","volume":"64","author":"Reagan-Steiner","year":"2015","journal-title":"MMWR Wkly Rep"},{"issue":"25","key":"2024013017363603900_B108","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1016\/j.vaccine.2011.11.113","article-title":"Parents\u2019 Internet use for information about HPV vaccine.","volume":"30","author":"McRee","year":"2012","journal-title":"Vaccine"},{"issue":"41","key":"2024013017363603900_B109","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1016\/j.vaccine.2012.07.045","article-title":"Do correlates of HPV vaccine initiation differ between adolescent boys and girls?","volume":"30","author":"Gilkey","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"2024013017363603900_B110","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2105\/AJPH.2012.301189","article-title":"Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males.","volume":"103","author":"Reiter","year":"2013","journal-title":"Am J Public Health"},{"issue":"26","key":"2024013017363603900_B111","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2013.04.010","article-title":"HPV vaccination among adolescent males: results from the National Immunization Survey-Teen.","volume":"31","author":"Reiter","year":"2013","journal-title":"Vaccine"},{"issue":"139","key":"2024013017363603900_B112","doi-asserted-by":"crossref","first-page":"e20164187","DOI":"10.1542\/peds.2016-4187","article-title":"Practical approaches to optimize adolescent immunization.","volume":"3","author":"Bernstein","year":"2017","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-4186\/1593312\/peds_20164186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-4186\/1593312\/peds_20164186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T17:37:24Z","timestamp":1706636244000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/139\/3\/e20164186\/53235\/The-Need-to-Optimize-Adolescent-Immunization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":112,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,1]]},"published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-4186","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]},"article-number":"e20164186"}}